XDR tuberculosis requires emphasis on primary transmission

The Lancet Infectious Diseases emphasises “poor prescribing practices” in its analysis of the emerging problem of extensively drug-resistant (XDR) tuberculosis1.

Although improved tuberculosis medication handling is essential, the largest study to date of XDR tuberculosis shows that those infected with the disease were never exposed to second-line drugs and most had never been treated for tuberculosis2.

Read the rest of the article here. Please note: you must register in order to access articles on The Lancet site.


 
For more, visit: https://www.bizcommunity.com